PhD (1995) in Pharmacy (Biochemistry), Universidade de Lisboa
Associate Professor (with Habilitation), Biochemistry and Human Biology, Faculdade de Farmácia, Universidade de Lisboa
Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
G Soveral is group leader of the Biological Transport Group (BioLTransp) dedicated to the study of membrane transport in biological systems. Our interests are (i) understanding membrane transport phenomena and mechanisms underlying transporters defects that may lead to disease, (ii) identifying transport systems as targets for drug action, (iii) screening of compounds as modulators of channels and transporters, with emphasis on aquaporin regulation and discovery of aquaporin inhibitors for diagnostic and therapeutic applications.
da Silva IV, Rodrigues JS, Rebelo I, Miranda JPG, Soveral G. Revisiting the metabolic syndrome: the emerging role of aquaglyceroporins. Cell Mol Life Sci 2018 [Epub ahead of print].
Direito I, Paulino J., Vigia E, Brito MA, Soveral G. Differential expression of aquaporin-3 and aquaporin-5 in pancreatic ductal adenocarcinoma. J Surg Oncol 2017; 115: 980-996.
Soveral G, Casini A. Aquaporin modulators: a patent review (2010-2015). Expert Opin Ther Pat 2017; 27: 49-60.
de Almeida A, Mósca AF, Wragg D, Wenzel M, Kavanagh P, Barone G, Leoni S, Soveral G, Casini A. The mechanism of aquaporin inhibition by gold compounds elucidated by biophysical and computational methods. Chem Commun (Camb) 2017; 53: 3830—3833.
Madeira A, Moura TF, Soveral G. Detecting aquaporin function and regulation. Front Chem 2016; 4:3.